NCT02319993

Brief Summary

keywords: Traditional Chinese Medicine, Herbs, Clinical trial, Insomnia, Quality of life, Suan-Zao-Ren Tang, Tian-wang-bu-xin-dan

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started May 2013

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
Last Updated

January 20, 2016

Status Verified

January 1, 2016

Enrollment Period

1.4 years

First QC Date

December 14, 2014

Last Update Submit

January 18, 2016

Conditions

Keywords

Suan-Zao-Ren TangTian-wang-bu-xin-danTraditional Chinese MedicineHerbsQuality of life

Outcome Measures

Primary Outcomes (1)

  • Pittsburgh Sleep Quality Index (PSQI)

    4 weeks

Secondary Outcomes (1)

  • World Health Organization Quality of Life questionnaire

    4 weeks

Study Arms (3)

TIAN WANG BU XIN DAN

EXPERIMENTAL

Drug:TIAN WANG BU XIN DAN CONCENRATED GRANULES "CHUANG SONG ZONG"

Drug: TIAN WANG BU XIN DAN

Suan Tzao Ren Tang

EXPERIMENTAL

Drug:Suan Tzao Ren Tang Granula Subtilae "CHUANG SONG ZONG"

Drug: Suan Tzao Ren Tang

Placebo

PLACEBO COMPARATOR

Drug:1/10 TIAN WANG BU XIN DAN

Drug: Placebo

Interventions

assigned to TWBXD (n =48) and were instructed to take 6 gm 2 times per day of TWBXD for a period of 4 weeks.

Also known as: TWBXD
TIAN WANG BU XIN DAN

assigned to SZRT (n = 48) and were instructed to take 6 gm 2 times per day of SZRT for a period of 4 weeks.

Also known as: STRT
Suan Tzao Ren Tang

1/10 TIAN WANG BU XIN DAN assigned to placebo (n =32) and were instructed to take 6 gm 2 times per day of placebo for a period of 4 weeks.

Also known as: P
Placebo

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Insomnia disorders in patients 20-80 years of age, the Pittsburgh Sleep Assessment Scale (PSQI)\> 6 points.
  • No insomnia caused by other diseases. For example: mental illness (depression, etc.), sleep apnea, heart disease (acute myocardial infarction, heart rate is not the whole), hypertension, diabetes, cancer and so on.
  • There are more than a week (including) three times to be more than 30 minutes to fall asleep and sleep less than six hours, there is a continuous months.
  • Test subjects had to really understand the nature of this study, and participants signed consent.

You may not qualify if:

  • Before participating in this study, three months, had a major accident or wheel graveyard shift or jet lag problems (such as a long flight).
  • Any insomnia caused by other diseases. For example: mental illness (depression, etc.), sleep apnea, heart disease (acute myocardial infarction), poorly controlled hypertension (\> 140 / 90mmHg), poorly controlled diabetes (HbA1C\> 7%), cancer, digestive ulcers (undergoing treatment).
  • weeks into the experiment of taking melatonin or melatonin agonist, acetylcholine, glutamate, serotonin, norepinephrine, GABA, histamine, adenosine, prostaglandins and other drugs.
  • If patients sleep disorders arise from nighttime urinary frequency. Pregnant or breastfeeding person.
  • Patients unable to read and fill out the questionnaire by themselves this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Critical Care Medicine and Division of Pulmonary Medicine

Study Record Dates

First Submitted

December 14, 2014

First Posted

December 19, 2014

Study Start

May 1, 2013

Primary Completion

October 1, 2014

Study Completion

October 1, 2014

Last Updated

January 20, 2016

Record last verified: 2016-01